New drug combo tested for Tough-to-Treat breast cancer
Disease control
Completed
This study tested a new two-drug combination for people with advanced triple-negative breast cancer that had spread and could not be removed by surgery. The main goals were to check the safety of the drugs together and see if they could shrink tumors. The trial involved 185 parti…
Phase: PHASE1, PHASE2 • Sponsor: Seagen Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC